Post on 13-Oct-2020
Rapid results with objective data at the point of treatment.
Aiding clinicians’ understanding of adherence and the root cause of treatment failure.
Test Menu
*Available with CE Mark. Others in Development.
Assay Description RUO CE
Clozapine*
For the rapid measurement of active drug in blood for monitoring patient adherence to antipsychotic therapy.
Olanzapine
Total Aripiprazole
Quetiapine
Total Risperidone
CLZ-MCI
OLZ-MCI
PAL-MCI
QTP-MCI
ARI-MCI
RSP-MCI
CLZ-MCI-RUO
OLZ-MCI-RUO
PAL-MCI-RUO
QTP-MCI-RUO
ARI-MCI-RUO
RSP-MCI-RUO
Paliperidone
Psychiatric drug adherenceshouldn’t be a question.
1 | Place the RFID card 3 | Insert the cartridge 4 | Close the door - done!
4-step procedure
2 | Collect the sample
The MyCaretm Insite Analyser provides valuable point of care testing for today’s psychiatry.
The Insite measures the blood levels of the most common antipsychotic drugs. Similar to a blood glucose test, Insite requires only a drop of blood taken by finger-stick and generates results in approximately 7 minutes. Conducting the test requires minimal training.
ConnectivityResults are transferred via ethernet connection or secure wi-fi
Web portal or computer connection available (selectable by configuration)
Compatible with most EMR
Fast. Simple. Accurate.
@MyCareTests /SaladaxBiomedical+1 610 419-6731hello@saladax.comMyCareTests.com
© 2019 Saladax Biomedical, Inc. MyCare™ is registered trademark of Saladax Biomedical, Inc. 116 Research Drive, Bethlehem, PA 18015 USA Tel: +1 610 419-6731MyCareTests.com LIT PSY-005 Rev 03
Contact Us Today
FactsSize: 160 x 135 x 145 mm, weight: 2.2 kg
LCD color touch screen
No manual calibration required
Requires minimal training
Allows input of Patient ID and Operator ID
Optional barcode reader and printer
The analyser software can easily be upgraded to accommodate future tests